Upregulation of TNF-α can also activate the NF-κB pathway resulting in the upregulation of other pro-inflammatory cytokines [87], which could potentially explain the significant increases in IL-6 and GM-CSF in the CFC group. The gene discussed is IL6; the disease is cardiofaciocutaneous syndrome.